NCT04132401View on ClinicalTrials.gov

AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

September 26, 2023

Conditions
Diabetic Retinopathy
Interventions
DIAGNOSTIC_TEST

algorithm

The diagnostic capacity of the algorithm will be compared with that of the family medicine physicians and with retina specialists. The reference will be a blinded double reading conducted by the retina specialists

Trial Locations (1)

08242

CAP Bages, Manresa

Sponsors

Collaborators (1)

OPTretina
All Listed Sponsors
collaborator

OPTretina

UNKNOWN

collaborator

Institut Català de la Salut

OTHER

collaborator

Department of Health, Generalitat de Catalunya

OTHER_GOV

lead

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER

NCT04132401 - AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care | Biotech Hunter | Biotech Hunter